G. Opdenakker

Cancer Research · 2000–2013

A researcher in the Science corpus: 6 papers; trusts 6 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom G. Opdenakker trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Christopher M. Overall
  2. P. E. Van den Steen
  3. W. Parks

Who trusts G. Opdenakker overall

  1. J. Vandooren
  2. P. E. Van den Steen
  3. Hao-Hsiu Huang

Papers from G. Opdenakker's perspective

Ordered by how strongly the researchers G. Opdenakker trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
  2. New functions for the matrix metalloproteinases in cancer progression (Nature Reviews. Cancer)
  3. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations (Science)
  4. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. (Science)
  5. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. (Blood)
  6. Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* (Journal of Biological Chemistry)
  7. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. (Cell)
  8. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.
  9. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. (Genes & Development)
  10. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. (Cell)

Their papers